Lexaria Bioscience Corp.’s $2.0 Million Public Offering

Leila Ahmed North America Legal Chronicle
Tagged:

Sichenzia Ross Ference LLP represented Lexaria Bioscience Corp. on the deal.Lexaria Bioscience Corp., (NASDAQ: “LEXX”), a global innovator in drug delivery platforms, announced a $2.0 million public…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here